Schrodinger, Inc. Gross Margin 2019-2024 | SDGR
Schrodinger, Inc. Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2024-09-30 | $0.19B | $0.13B | 65.28% |
2024-06-30 | $0.20B | $0.13B | 65.67% |
2024-03-31 | $0.19B | $0.12B | 60.85% |
2023-12-31 | $0.22B | $0.14B | 65.44% |
2023-09-30 | $0.20B | $0.12B | 61.50% |
2023-06-30 | $0.19B | $0.12B | 59.79% |
2023-03-31 | $0.20B | $0.12B | 60.41% |
2022-12-31 | $0.18B | $0.10B | 55.80% |
2022-09-30 | $0.17B | $0.09B | 51.76% |
2022-06-30 | $0.16B | $0.08B | 50.31% |
2022-03-31 | $0.16B | $0.08B | 49.68% |
2021-12-31 | $0.14B | $0.07B | 47.10% |
2021-09-30 | $0.13B | $0.06B | 46.40% |
2021-06-30 | $0.12B | $0.06B | 51.24% |
2021-03-31 | $0.11B | $0.06B | 56.14% |
2020-12-31 | $0.11B | $0.06B | 59.26% |
2020-09-30 | $0.10B | $0.06B | 60.40% |
2020-06-30 | $0.10B | $0.06B | 60.00% |
2020-03-31 | $0.09B | $0.05B | 58.24% |
2019-12-31 | $0.09B | $0.05B | 58.14% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. |